DUBLIN, June 12, 2013 /PRNewswire/ --
Research and Markets (http://www.researchandmarkets.com/research/b7j88d/research_report) has announced the addition of the "Research Report on China's Antidepressant Market, 2013-2017" report to their offering.
Oct. 10 is "World Mental Health Day". In 2012, its theme is "Depression: a Global Crisis". According to statistics from the United Nations, about 350 million people suffer from depression in the world. Approximately one million people commit suicide every year because of depression, thus depression becomes a health crisis worldwide.
In developed countries, the sales volume of medicines for depression and anxiety disorder amounts to 45% of market share of nervous centralis medicines. Depressant medicines and schizophrenia drugs totally account for 80% of world's mental disorder medicines. There are totally 50 to 60 varieties of antidepressants on the market or in development, which is more than therapeutic agents of schizophrenia. According to reports, the current eight best-selling antidepressants globally are Fluoxetine, Paroxetine, Sertraline, Fluvoxamine, Venlafaxine, Mirtazapine, Duloxetine and Amitriptyline, and the total sales amount exceeds 80% of global antidepressant market.
With the rapid development of economy, continuous improvement in people's living standards, continuously-intensified social competition, recombination of labour forces and changes in population and family structures, depression presents an obviously increasing trend in China. It is estimated that there are over 30 milli
|SOURCE Research and Markets|
Copyright©2012 PR Newswire.
All rights reserved